ciclopirox 80 MG/ML Topical Solution

What the CMS Formulary Data Shows for ciclopirox 80 MG/ML Topical Solution

Per the CMS 2026 Part D formulary file, ciclopirox 80 MG/ML Topical Solution (RxNorm concept RXCUI 309291, generic name ciclopirox) appears on 265 distinct formulary files spanning 4,068 Medicare Part D plan offerings - 80.3% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.9.

Real-world access to ciclopirox 80 MG/ML Topical Solution depends on utilization management as much as tier placement: 7.5% of covering formularies require prior authorization. 0% require step therapy. 69.8% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 397,306 Part D beneficiaries filled ciclopirox 80 MG/ML Topical Solution in 2023, with total plan-and-beneficiary spending of $28,729,532 and an average per-beneficiary annual cost of $72.31. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ciclopirox 80 MG/ML Topical Solution today.